Rani Therapeutics

Rani Therapeutics has developed RaniPill™, a platform technology for the oral delivery of biologics. Injectable medications are painful and inconvenient, negatively impacting patient compliance and quality of life over the long term. The pharmaceutical industry has been seeking ways to convert injections into pills, and we believe the solution is the RaniPill™ capsule. In preclinical and clinical studies, we have demonstrated bioavailability of the oral medication comparable to subcutaneous injections. Rani Therapeutics has an internal pipeline of molecules and active collaborations with Novartis and Takeda. The research and technology behind Rani Therapeutics originate from InCube Labs, a multidisciplinary life science R&D lab focused on breakthrough medical innovations.